Immune Thrombocytopenia Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Immune Thrombocytopenia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Thrombocytopenia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Thrombocytopenia Treatment Overall Market Size
2.1 Global Immune Thrombocytopenia Treatment Market Size: 2023 VS 2030
2.2 Global Immune Thrombocytopenia Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immune Thrombocytopenia Treatment Players in Global Market
3.2 Top Global Immune Thrombocytopenia Treatment Companies Ranked by Revenue
3.3 Global Immune Thrombocytopenia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Immune Thrombocytopenia Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Immune Thrombocytopenia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune Thrombocytopenia Treatment Players in Global Market
3.6.1 List of Global Tier 1 Immune Thrombocytopenia Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Immune Thrombocytopenia Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune Thrombocytopenia Treatment Market Size Markets, 2023 & 2030
4.1.2 Corticosteroids
4.1.3 Intravenous Immunoglobulin (IVIG)
4.1.4 Anti-D Immunoglobulin
4.1.5 Thrombopoietin Receptor Agonist (TPO-RA)
4.1.6 Others
4.2 By Type - Global Immune Thrombocytopenia Treatment Revenue & Forecasts
4.2.1 By Type - Global Immune Thrombocytopenia Treatment Revenue, 2019-2024
4.2.2 By Type - Global Immune Thrombocytopenia Treatment Revenue, 2025-2030
4.2.3 By Type - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune Thrombocytopenia Treatment Market Size, 2023 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Research and Academic Institutes
5.1.4 Others
5.2 By Application - Global Immune Thrombocytopenia Treatment Revenue & Forecasts
5.2.1 By Application - Global Immune Thrombocytopenia Treatment Revenue, 2019-2024
5.2.2 By Application - Global Immune Thrombocytopenia Treatment Revenue, 2025-2030
5.2.3 By Application - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Immune Thrombocytopenia Treatment Market Size, 2023 & 2030
6.2 By Region - Global Immune Thrombocytopenia Treatment Revenue & Forecasts
6.2.1 By Region - Global Immune Thrombocytopenia Treatment Revenue, 2019-2024
6.2.2 By Region - Global Immune Thrombocytopenia Treatment Revenue, 2025-2030
6.2.3 By Region - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Immune Thrombocytopenia Treatment Revenue, 2019-2030
6.3.2 US Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.3.3 Canada Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.3.4 Mexico Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Immune Thrombocytopenia Treatment Revenue, 2019-2030
6.4.2 Germany Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4.3 France Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4.4 U.K. Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4.5 Italy Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4.6 Russia Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.4.8 Benelux Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Immune Thrombocytopenia Treatment Revenue, 2019-2030
6.5.2 China Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.5.3 Japan Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.5.4 South Korea Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.5.6 India Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Immune Thrombocytopenia Treatment Revenue, 2019-2030
6.6.2 Brazil Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.6.3 Argentina Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immune Thrombocytopenia Treatment Revenue, 2019-2030
6.7.2 Turkey Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.7.3 Israel Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Immune Thrombocytopenia Treatment Market Size, 2019-2030
6.7.5 UAE Immune Thrombocytopenia Treatment Market Size, 2019-2030
7 Immune Thrombocytopenia Treatment Companies Profiles
7.1 CSL Behring
7.1.1 CSL Behring Company Summary
7.1.2 CSL Behring Business Overview
7.1.3 CSL Behring Immune Thrombocytopenia Treatment Major Product Offerings
7.1.4 CSL Behring Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.1.5 CSL Behring Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Immune Thrombocytopenia Treatment Major Product Offerings
7.2.4 Amgen Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.2.5 Amgen Key News & Latest Developments
7.3 F.Hoffmann-La Roche
7.3.1 F.Hoffmann-La Roche Company Summary
7.3.2 F.Hoffmann-La Roche Business Overview
7.3.3 F.Hoffmann-La Roche Immune Thrombocytopenia Treatment Major Product Offerings
7.3.4 F.Hoffmann-La Roche Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.3.5 F.Hoffmann-La Roche Key News & Latest Developments
7.4 Kyowa Hakko Kirin
7.4.1 Kyowa Hakko Kirin Company Summary
7.4.2 Kyowa Hakko Kirin Business Overview
7.4.3 Kyowa Hakko Kirin Immune Thrombocytopenia Treatment Major Product Offerings
7.4.4 Kyowa Hakko Kirin Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.4.5 Kyowa Hakko Kirin Key News & Latest Developments
7.5 Rigel Pharmaceuticals
7.5.1 Rigel Pharmaceuticals Company Summary
7.5.2 Rigel Pharmaceuticals Business Overview
7.5.3 Rigel Pharmaceuticals Immune Thrombocytopenia Treatment Major Product Offerings
7.5.4 Rigel Pharmaceuticals Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.5.5 Rigel Pharmaceuticals Key News & Latest Developments
7.6 Shionogi
7.6.1 Shionogi Company Summary
7.6.2 Shionogi Business Overview
7.6.3 Shionogi Immune Thrombocytopenia Treatment Major Product Offerings
7.6.4 Shionogi Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.6.5 Shionogi Key News & Latest Developments
7.7 Dova Pharmaceuticals
7.7.1 Dova Pharmaceuticals Company Summary
7.7.2 Dova Pharmaceuticals Business Overview
7.7.3 Dova Pharmaceuticals Immune Thrombocytopenia Treatment Major Product Offerings
7.7.4 Dova Pharmaceuticals Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.7.5 Dova Pharmaceuticals Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Immune Thrombocytopenia Treatment Major Product Offerings
7.8.4 Novartis Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.8.5 Novartis Key News & Latest Developments
7.9 Shire
7.9.1 Shire Company Summary
7.9.2 Shire Business Overview
7.9.3 Shire Immune Thrombocytopenia Treatment Major Product Offerings
7.9.4 Shire Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.9.5 Shire Key News & Latest Developments
7.10 Ligand Pharmaceuticals
7.10.1 Ligand Pharmaceuticals Company Summary
7.10.2 Ligand Pharmaceuticals Business Overview
7.10.3 Ligand Pharmaceuticals Immune Thrombocytopenia Treatment Major Product Offerings
7.10.4 Ligand Pharmaceuticals Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.10.5 Ligand Pharmaceuticals Key News & Latest Developments
7.11 GSK
7.11.1 GSK Company Summary
7.11.2 GSK Business Overview
7.11.3 GSK Immune Thrombocytopenia Treatment Major Product Offerings
7.11.4 GSK Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.11.5 GSK Key News & Latest Developments
7.12 Grifols Biologicals
7.12.1 Grifols Biologicals Company Summary
7.12.2 Grifols Biologicals Business Overview
7.12.3 Grifols Biologicals Immune Thrombocytopenia Treatment Major Product Offerings
7.12.4 Grifols Biologicals Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.12.5 Grifols Biologicals Key News & Latest Developments
7.13 Jiangsu Hengrui Pharmaceutical
7.13.1 Jiangsu Hengrui Pharmaceutical Company Summary
7.13.2 Jiangsu Hengrui Pharmaceutical Business Overview
7.13.3 Jiangsu Hengrui Pharmaceutical Immune Thrombocytopenia Treatment Major Product Offerings
7.13.4 Jiangsu Hengrui Pharmaceutical Immune Thrombocytopenia Treatment Revenue in Global Market (2019-2024)
7.13.5 Jiangsu Hengrui Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Immune Thrombocytopenia Treatment Market Opportunities & Trends in Global Market
Table 2. Immune Thrombocytopenia Treatment Market Drivers in Global Market
Table 3. Immune Thrombocytopenia Treatment Market Restraints in Global Market
Table 4. Key Players of Immune Thrombocytopenia Treatment in Global Market
Table 5. Top Immune Thrombocytopenia Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Immune Thrombocytopenia Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Immune Thrombocytopenia Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Immune Thrombocytopenia Treatment Product Type
Table 9. List of Global Tier 1 Immune Thrombocytopenia Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Thrombocytopenia Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Immune Thrombocytopenia Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Immune Thrombocytopenia Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Immune Thrombocytopenia Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Immune Thrombocytopenia Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Immune Thrombocytopenia Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Immune Thrombocytopenia Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2025-2030
Table 30. CSL Behring Company Summary
Table 31. CSL Behring Immune Thrombocytopenia Treatment Product Offerings
Table 32. CSL Behring Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. CSL Behring Key News & Latest Developments
Table 34. Amgen Company Summary
Table 35. Amgen Immune Thrombocytopenia Treatment Product Offerings
Table 36. Amgen Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. Amgen Key News & Latest Developments
Table 38. F.Hoffmann-La Roche Company Summary
Table 39. F.Hoffmann-La Roche Immune Thrombocytopenia Treatment Product Offerings
Table 40. F.Hoffmann-La Roche Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. F.Hoffmann-La Roche Key News & Latest Developments
Table 42. Kyowa Hakko Kirin Company Summary
Table 43. Kyowa Hakko Kirin Immune Thrombocytopenia Treatment Product Offerings
Table 44. Kyowa Hakko Kirin Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Kyowa Hakko Kirin Key News & Latest Developments
Table 46. Rigel Pharmaceuticals Company Summary
Table 47. Rigel Pharmaceuticals Immune Thrombocytopenia Treatment Product Offerings
Table 48. Rigel Pharmaceuticals Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Rigel Pharmaceuticals Key News & Latest Developments
Table 50. Shionogi Company Summary
Table 51. Shionogi Immune Thrombocytopenia Treatment Product Offerings
Table 52. Shionogi Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. Shionogi Key News & Latest Developments
Table 54. Dova Pharmaceuticals Company Summary
Table 55. Dova Pharmaceuticals Immune Thrombocytopenia Treatment Product Offerings
Table 56. Dova Pharmaceuticals Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Dova Pharmaceuticals Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Immune Thrombocytopenia Treatment Product Offerings
Table 60. Novartis Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Shire Company Summary
Table 63. Shire Immune Thrombocytopenia Treatment Product Offerings
Table 64. Shire Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 65. Shire Key News & Latest Developments
Table 66. Ligand Pharmaceuticals Company Summary
Table 67. Ligand Pharmaceuticals Immune Thrombocytopenia Treatment Product Offerings
Table 68. Ligand Pharmaceuticals Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 69. Ligand Pharmaceuticals Key News & Latest Developments
Table 70. GSK Company Summary
Table 71. GSK Immune Thrombocytopenia Treatment Product Offerings
Table 72. GSK Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 73. GSK Key News & Latest Developments
Table 74. Grifols Biologicals Company Summary
Table 75. Grifols Biologicals Immune Thrombocytopenia Treatment Product Offerings
Table 76. Grifols Biologicals Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 77. Grifols Biologicals Key News & Latest Developments
Table 78. Jiangsu Hengrui Pharmaceutical Company Summary
Table 79. Jiangsu Hengrui Pharmaceutical Immune Thrombocytopenia Treatment Product Offerings
Table 80. Jiangsu Hengrui Pharmaceutical Immune Thrombocytopenia Treatment Revenue (US$, Mn) & (2019-2024)
Table 81. Jiangsu Hengrui Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Immune Thrombocytopenia Treatment Segment by Type in 2023
Figure 2. Immune Thrombocytopenia Treatment Segment by Application in 2023
Figure 3. Global Immune Thrombocytopenia Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Immune Thrombocytopenia Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Immune Thrombocytopenia Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune Thrombocytopenia Treatment Revenue in 2023
Figure 8. By Type - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 16. US Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 28. China Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Immune Thrombocytopenia Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Immune Thrombocytopenia Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. CSL Behring Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Amgen Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. F.Hoffmann-La Roche Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Kyowa Hakko Kirin Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Rigel Pharmaceuticals Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Shionogi Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Dova Pharmaceuticals Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Novartis Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Shire Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Ligand Pharmaceuticals Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. GSK Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Grifols Biologicals Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Jiangsu Hengrui Pharmaceutical Immune Thrombocytopenia Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Industry Market Size
